Seagen Inc.
Glycan-interacting compounds and methods of use
Last updated:
Abstract:
Methods of treating cancer are provided that include administering glycan-interacting antibodies. Included are anti-sialyl Tn antigen antibodies and related compositions and formulations suitable to achieve desirable bioactivity, bioavailability, and toxicity levels.
Status:
Grant
Type:
Utility
Filling date:
2 Mar 2018
Issue date:
22 Feb 2022